18 Jul 2023

Successful bioequivalence studies for Bempedoic Acid and Bempedoic Acid + Ezetimibe in US

Synthon successfully completes bioequivalence studies for Bempedoic Acid and Bempedoic Acid + Ezetimibe in US.

read more
24 May 2023

Synthon announces successful bioequivalence studies for Bempedoic acid

Synthon is proud to announce the completion of two successful bioequivalence (BE) studies for Bempedoic acid, a product we are developing for our…

read more
13 Feb 2023

Synthon at DCAT Week 2023 in New York

We are thrilled to meet our business partners, industry colleagues and friends at DCAT Week in New York City from March 20-23, 2023.

read more
20 Dec 2022

Synthon donates to Amalia Children's Hospital

Synthon donates a financial gift and materials to Amalia Children's Hospital.

read more
08 Dec 2022

Synthon and SAJA sign agreement to commercialize a basket of products

Synthon is pleased to announce that it has entered into a partnership with Saudi-based SAJA, to commercialize several products in KSA and GCC region.

read more
21 Sept 2022

We are attending CPHI 2022

You will be able to find us at the the upcoming international pharma event from CPHI Worldwide 2022 in Frankfurt, Germany.

read more
05 Jul 2022

Support Team Wikke

Our colleague Liselijn Wisman is raising funds during de Nijmeegse Vierdaagse for the Oogfonds. Her son Wikke has the rare Leber's disease.

read more
20 Jan 2022

Synthon Hispania certified by Top Employers Institute 2022

The Top Employer Institute certified Synthon Hispania as a reference company: one of the organizations with the best conditions for their employees…

read more
14 Dec 2021

New Chief Commercial Officer

John McCullough has been appointed as Chief Commercial Officer.

read more
17 Sept 2021

Synthon anniversary: 30 years of science, people and affordable medicines

17th of September 2021 marks a very special day in the history of Synthon. For 30 years we have been putting great science to work to bring affordable…

read more